Abstract
Background: Diabetes Mellitus (DM) is a common medical condition affecting more than 6% of the world population. Besides well-known pathology like diabetic retinopathy and renal insufficiency, it carries important orthopedic implications, especially around the foot and ankle (diabetic foot).
Focus: This article focusses on the three major areas confronting the orthopedist: 1) changes in foot statics and biology leading to ulceration with or without osteomyelitis, 2) ankle fractures, particularly complications after a fracture and 3) Charcot foot.
Their pathophysiology, clinical features, classification, diagnostic dilemmas and treatment options are discussed.
Conclusion: DM is very common and is often associated with foot problems. Diabetic foot is a special condition that needs special attention. This article aims to provide the necessary knowledge to a better understanding and treatment of the diabetic foot.
Keywords: Diabetic foot, diabetes mellitus, orthopedic surgery, orthopedic shoe, charcot, neuropathy, ankle fracture.
Current Pharmaceutical Design
Title:Orthopedic Aspects of the Diabetic Foot
Volume: 24 Issue: 12
Author(s): Elvira J.A. Tijdens-Creusen, Paul C. Jutte*, Wim M.H.H. Schoumakers, Melanie M. Van der Klauw and Marjan Wouthuyzen-Bakker
Affiliation:
- Department of Orthopaedic Surgery, University of Groningen, University Medical Center Groningen, Groningen,Netherlands
Keywords: Diabetic foot, diabetes mellitus, orthopedic surgery, orthopedic shoe, charcot, neuropathy, ankle fracture.
Abstract: Background: Diabetes Mellitus (DM) is a common medical condition affecting more than 6% of the world population. Besides well-known pathology like diabetic retinopathy and renal insufficiency, it carries important orthopedic implications, especially around the foot and ankle (diabetic foot).
Focus: This article focusses on the three major areas confronting the orthopedist: 1) changes in foot statics and biology leading to ulceration with or without osteomyelitis, 2) ankle fractures, particularly complications after a fracture and 3) Charcot foot.
Their pathophysiology, clinical features, classification, diagnostic dilemmas and treatment options are discussed.
Conclusion: DM is very common and is often associated with foot problems. Diabetic foot is a special condition that needs special attention. This article aims to provide the necessary knowledge to a better understanding and treatment of the diabetic foot.
Export Options
About this article
Cite this article as:
Tijdens-Creusen J.A. Elvira, Jutte C. Paul *, Schoumakers M.H.H. Wim, Van der Klauw M. Melanie and Wouthuyzen-Bakker Marjan, Orthopedic Aspects of the Diabetic Foot, Current Pharmaceutical Design 2018; 24 (12) . https://dx.doi.org/10.2174/1381612824666180328120347
DOI https://dx.doi.org/10.2174/1381612824666180328120347 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Glucose Control and Use of Continuous Glucose Monitoring in the Intensive Care Unit: A Critical Review
Current Diabetes Reviews Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer
Current Pharmaceutical Biotechnology The Factors Associated with the Length of the Third Stage of Labour: A Descriptive-Analytical Study
Current Women`s Health Reviews The Role of Obesity in the Development of Polycystic Ovary Syndrome
Current Pharmaceutical Design Balancing Antioxidant, Hypolipidemic and Anti-inflammatory Activity in a Single Agent: The Example of 2-Hydroxy-2-Substituted Morpholine, 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives as a Rational Therapeutic Approach against Atherosclerosis
Current Medicinal Chemistry Recent Developments in Medicinal Chemistry of Allosteric Activators of Human Glucokinase for Type 2 Diabetes Mellitus Therapeutics
Current Pharmaceutical Design Virtual Screening, Docking, Synthesis and Bioactivity Evaluation of Thiazolidinediones as Potential PPARγ Partial Agonists for Preparation of Antidiabetic Agents
Letters in Drug Design & Discovery Vascular Cognitive Disorder: A Diagnostic and Pharmacological Treatment Updating
Current Psychopharmacology Drug Delivery Systems for the Treatment of Diabetes Mellitus: State of the Art
Current Pharmaceutical Design Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome
Current Vascular Pharmacology Regulating the Beta Cell Mass as a Strategy for Type-2 Diabetes Treatment
Current Drug Targets Vitamin D Therapy in Cardiac Hypertrophy and Heart Failure
Current Pharmaceutical Design Ghrelin and Motilin in the Gastrointestinal System
Current Pharmaceutical Design Alzheimer Disease and Diabetes Mellitus: Do They have Anything in Common?
Current Alzheimer Research New Horizons in Diabetes Therapy: The Angiogenesis Paradox in Diabetes: Description of the Problem and Presentation of a Unifying Hypothesis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Renin-Angiotensin Antagonists: Therapeutic Effects Beyond Blood Pressure Control?
Current Pharmaceutical Design Efficacy and Cardiovascular Safety of Alpha Glucosidase Inhibitors
Current Drug Safety Glucose Transporter and Na+ / glucose Cotransporter as Molecular Targets of Anti-Diabetic Drugs
Current Medicinal Chemistry Role of Vascular Progenitor Cells in Cardiovascular Disease
Current Pharmaceutical Design Ultra-Fast Acting Insulin Analogues
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)